Larvol Delta - Actinium-225-Labeled-AntiCEA-Antibody-Ac225DOTAM5A-for-the-Treatment-of-CEA-Producing-Advanced-or-Metastatic-Cancers

Ac225-DOTA-M5A - City of Hope, National Cancer Institute - Bethesda

http://clinicaltrials.gov/ct2/show/NCT05204147

Aug 27, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next